Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators.
The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy. We used an adenoviral technique of blocking NF-kappaB through overexpression of the inhibitory subunit IkappaBalpha, which has the advantage that it can be used in the d...
Asıl Yazarlar: | Bondeson, J, Foxwell, B, Brennan, F, Feldmann, M |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
1999
|
Benzer Materyaller
-
NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts.
Yazar:: Smith, C, ve diğerleri
Baskı/Yayın Bilgisi: (2001) -
Is NF-kappaB a useful therapeutic target in rheumatoid arthritis?
Yazar:: Feldmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (2002) -
Antigen-specific T-cell downregulation by human dendritic cells following blockade of NF-kappaB.
Yazar:: Calder, V, ve diğerleri
Baskı/Yayın Bilgisi: (2003) -
Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines.
Yazar:: Yoshimura, S, ve diğerleri
Baskı/Yayın Bilgisi: (2001) -
Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant.
Yazar:: Andreakos, E, ve diğerleri
Baskı/Yayın Bilgisi: (2006)